Heidi Glosli

Medical Doctor
Division of Paediatric and Adolescent Medicine Centre for Rare Disorders Oslo University Hospital Oslo Norway.

Presentation(s):

• PB1126 - Safety and efficacy of simoctocog alfa in patients with haemophilia A in routine clinical practice (GENA-99)

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1153 - Interim Analysis from B-MORE, a 24-month Prospective, Multicentre, Non-interventional Study on Effectiveness and Usage of Recombinant Factor IX Fc (rFIXFc) in Haemophilia B

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1175 - Norwegian Real-World Experience with recombinant factor IX Fc (rFIXFc) in Haemophilia B (HB) Patients

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1176 - Norwegian Real-World Experience with recombinant factor VIII Fc (rFVIIIFc) in Haemophilia A (HA) Patients

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM